Vision Care: The PPS Revenue Lever 3 of 4 FQHCs Are Missing

The headline: vision PPS economics are unusually strong

California FQHCs operate on a Prospective Payment System (PPS) where a face-to-face medically necessary visit by an optometrist qualifies for the full FQHC encounter rate. Site-specific rates vary, but a conservative $300 per encounter is well below the typical California cost-based rate (many established FQHCs exceed $400). The Medicare FQHC PPS national base rate for CY2024 was $195.99, but California Medi-Cal site-specific rates are clinic-specific and generally materially higher.

At a conservative 60% capacity ramp — 15 patients per day, 240 work days, 3,600 encounters annually — a single OD lane generates approximately $1.08 million in PPS revenue. After labor costs ($287,000 all-in for OD, optician, and ophthalmic technician), supplies, and amortized capital, the line margin lands near $700,000 per year per OD.

Compare this to private-practice optometry, where margin per exam runs $120-180 in commercial settings. The FQHC PPS structure converts what is otherwise a thin commercial margin into a near-pure-revenue line. This is the single biggest financial argument for vision investment — and most FQHC executives don't run the numbers because they assume vision is a charitable add-on.

AI is the second economic argument — and it's stronger than you think

Most FQHC executives don't know this: the FIRST FDA-authorized autonomous AI in any field of medicine was for diabetic retinopathy. Digital Diagnostics' LumineticsCore (formerly IDx-DR) received FDA De Novo authorization on April 11, 2018 — eight years ago. Since then, two more autonomous AI systems for DR have been FDA-cleared (EyeArt by Eyenuk in 2020, AEYE-DS by AEYE Health in 2022, expanded for portable handheld in 2024).

CMS deliberately reimburses autonomous AI MORE than human interpretation. CPT 92229 (autonomous AI imaging) pays $43.67 in 2025, up from $40.94 in 2024. CPT 92228 (MD interpretation) pays $29.14. CPT 92227 (staff review) pays $17.35. The price differential is intentional policy: CMS uses reimbursement to drive AI adoption in primary care.

The real-world FQHC implementation data is striking. Cahaba Medical Care, an Alabama FQHC, deployed LumineticsCore and detected previously-missed diabetic retinopathy in MORE THAN 1-IN-4 patients screened. For an FQHC with a 1,000+ diabetic patient panel, that translates to ~250 patients with vision-threatening pathology surfaced who would otherwise have been missed. Compare AI vendors with our AI Selection Wizard.

The California-specific story is the children's vision crisis

Only 16% of school-age California Medi-Cal kids got an eye exam between 2022 and 2024 — DOWN from 19% eight years earlier. 47 of 58 California counties got worse. CalMatters' April 2026 investigation traced the cause to two structural failures: California Medi-Cal pays approximately $47 per comprehensive eye exam, unchanged for 25 years; and only ~10% of California Optometric Association members accept Medi-Cal at this rate.

California Education Code §49455 mandates vision screening at kindergarten and grades 2, 5, and 8. The screening happens. The follow-up exam often does not. Children fail the school screening, get a referral letter home, and the referral dies because no provider in the network accepts Medi-Cal at $47 per exam.

FQHCs are the only realistic capacity expansion vehicle. Vision To Learn — the LA-founded school-based mobile clinic operator — has done more LAUSD eye exams (55,000+) than any FQHC. Warby Parker's Pupils Project + Vision To Learn expanded to 75 California school districts in 2025 — the largest single school-vision footprint in the state. The opportunity for FQHCs: partner with these mobile operators to handle medical-grade follow-up of children flagged at school screening. Build the school-FQHC MOU using our guide.

The two structural barriers (and how to navigate them)

Optometrists are NOT NHSC-eligible. The FY2026 NHSC Loan Repayment Application Guidance lists eligible disciplines: MD/DO, NP, PA, CNM, dental (DDS/DMD), dental hygienists, CRNAs, behavioral health providers. Optometry is excluded. Optometry was historically eligible but was removed; the AOA has been lobbying for restoration via the NHSC Improvement Act (HR 920 / S. 1445).

This is the single largest federal workforce policy headwind for FQHC vision care. Dental and primary care providers can pursue $50,000 in tax-free loan repayment for 2-year service. ODs cannot. FQHCs recruiting ODs must compete with private optometry without the NHSC hook that boosts dental and primary care recruitment.

Vision is also non-mandatory under HRSA Section 330. Per HRSA Health Center Program Compliance FAQs, eyeglasses (along with hearing aids and dentures) are explicitly excluded from in-scope services and are NOT subject to the sliding-fee discount mandate. The implication: HRSA grant funds CANNOT be used for eyewear inventory, and Section 330 base grants cannot launch a new vision service line. Vision investment must come from expansion grants, 340B savings, or operating capital.

Counter-intuitively, ACU's 2023 FQHC Optometry Workforce Survey found that rural FQHC optometrists earn MORE than urban ($168K vs $151K average — a $17K rural premium) due to acute rural-recruitment compensation. The conventional 'rural pays less' assumption is wrong for FQHC vision care.

California FQHCs already proving the model

Family Health Centers of San Diego (FHCSD) operates 5 dedicated vision clinics — among the largest FQHC vision program footprints in the US. North East Medical Services (NEMS) runs 5 sites across SF / Daly City / San Jose with an in-house ophthalmologist serving the largest AAPI-majority FQHC vision program in CA. La Clínica de la Raza supervises a OneSight-supported school vision center in Oakland Unified School District — model FQHC + school partnership.

Watts Healthcare is the only CA FQHC profile naming pediatric low vision, bi-optics, prism, and specialty filter prescriptions — suggesting genuine specialty vision capability beyond basic refraction. Alliance Medical Center launched the only confirmed CA FQHC-operated mobile vision van, serving rural Sonoma farmworker communities. Tarzana Treatment Centers has documented LumineticsCore AI deployment.

And San Ysidro Health is running the most rigorous CA FQHC AI vision trial currently underway: DRES-POCAI (Diabetic Retinopathy Screening with Point-of-Care AI), 848 patients across 2 FQHC sites, EyeArt point-of-care AI integrated with the EHR. Funded by the Gordon and Betty Moore Foundation + Kaiser Permanente AIM-HI. ClinicalTrials.gov NCT06721351. Trial protocol published in JAMA Network Open. Outcomes will inform NACHC/AOA/CHCF policy on autonomous AI DR screening reimbursement. Browse all 4 case studies.

The decision tree for FQHC executives in 2026

If you have a diabetic patient panel of 1,000+ and don't currently offer vision care, the highest-ROI move available to you in 2026 is deploying autonomous AI for diabetic retinopathy screening. Capital cost: $15-50K for a Topcon NW400 fundus camera (refurbished from $3,278). AI subscription via LumineticsCore, EyeArt, or AEYE-DS. CPT 92229 reimburses $43.67 per screening. The equipment pays for itself within months. The HEDIS Eye Exam for Patients with Diabetes (EED) quality measure improvement captures Medi-Cal Managed Care quality bonuses on top.

If you can take on workforce and capital costs, build a full vision service line. Hire 1 OD ($140-185K CA salary), 1 optician ($45-60K), 1 ophthalmic technician ($45-65K), allocate $200-300K capital for 2 exam lanes + dispensary inventory. Year 1 ramp at 60% capacity hits $900K-1M revenue. Year 2 steady state generates $700K+ line margin. Co-locate with primary care to capture same-day multi-encounter billing. Establish MOUs with Vision To Learn / Warby Parker Pupils Project for K-12 referral pipeline. Partner with VSP Eyes of Hope (CA-HQ in Rancho Cordova) for charitable adult care. Open the 90-Day Launch Playbook.

Then commit to advocacy. The NHSC Improvement Act (HR 920 / S. 1445) is the largest federal workforce lever for FQHC vision care. The Medi-Cal $47 optometry rate (unchanged for 25 years) is the largest state policy lever. FQHCs that operate vision care AND advocate for the policy fixes lead the narrative. FQHCs that do neither will react to whatever happens. Push the policy fix from our advocacy tracker.